CD40LG and COVID-19: Drawbacks of the study include the limited sample size, as well as the restricted number of newborns from pregnant women with COVID-19 that were tested with RT-PCR or cord-blood SARS-CoV-2 IgG and IgM antibodies within 24 hours after delivery.